HomeTYP • ASX
add
Tryptamine Therapeutics Ltd
Previous close
$0.036
Day range
$0.037 - $0.037
Year range
$0.017 - $0.057
Market cap
41.98M AUD
Avg Volume
2.05M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Investopedia
1 day ago
Supermicro Stock Jumps to Lead S&P 500 Gainers Friday as JPMorgan Boosts
Rating
7.80%
1.10%
0.082%
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.09M | 143.64% |
Net income | -2.01M | -45.93% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.97M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.87M | 502.10% |
Total assets | 5.30M | 563.93% |
Total liabilities | 1.06M | -85.75% |
Total equity | 4.24M | — |
Shares outstanding | 1.28B | — |
Price to book | ∞ | — |
Return on assets | -93.67% | — |
Return on capital | -115.74% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.01M | -45.93% |
Cash from operations | -2.51M | -34.11% |
Cash from investing | -60.36K | — |
Cash from financing | 1.28M | 5,663.74% |
Net change in cash | -1.25M | 32.64% |
Free cash flow | -1.26M | 36.14% |
About
Founded
2019
Website
